Cargando…
Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
One of the most effective cancer therapies, cancer immunotherapy has produced outstanding outcomes in the field of cancer treatment. However, the cost is excessive, which limits its applicability. A smart way to address this issue would be to apply the knowledge gained through immunotherapy to devel...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610880/ https://www.ncbi.nlm.nih.gov/pubmed/36298592 http://dx.doi.org/10.3390/vaccines10101727 |
_version_ | 1784819387915567104 |
---|---|
author | Koyande, Navami Prabhakar Srivastava, Rupali Padmakumar, Ananya Rengan, Aravind Kumar |
author_facet | Koyande, Navami Prabhakar Srivastava, Rupali Padmakumar, Ananya Rengan, Aravind Kumar |
author_sort | Koyande, Navami Prabhakar |
collection | PubMed |
description | One of the most effective cancer therapies, cancer immunotherapy has produced outstanding outcomes in the field of cancer treatment. However, the cost is excessive, which limits its applicability. A smart way to address this issue would be to apply the knowledge gained through immunotherapy to develop strategies for the immunoprevention of cancer. The use of cancer vaccines is one of the most popular methods of immunoprevention. This paper reviews the technologies and processes that support the advantages of cancer immunoprevention over traditional cancer immunotherapies. Nanoparticle drug delivery systems and nanoparticle-based nano-vaccines have been employed in the past for cancer immunotherapy. This paper outlines numerous immunoprevention strategies and how nanotechnology can be applied in immunoprevention. To comprehend the non-clinical and clinical evaluation of these cancer vaccines through clinical studies is essential for acceptance of the vaccines. |
format | Online Article Text |
id | pubmed-9610880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96108802022-10-28 Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review Koyande, Navami Prabhakar Srivastava, Rupali Padmakumar, Ananya Rengan, Aravind Kumar Vaccines (Basel) Review One of the most effective cancer therapies, cancer immunotherapy has produced outstanding outcomes in the field of cancer treatment. However, the cost is excessive, which limits its applicability. A smart way to address this issue would be to apply the knowledge gained through immunotherapy to develop strategies for the immunoprevention of cancer. The use of cancer vaccines is one of the most popular methods of immunoprevention. This paper reviews the technologies and processes that support the advantages of cancer immunoprevention over traditional cancer immunotherapies. Nanoparticle drug delivery systems and nanoparticle-based nano-vaccines have been employed in the past for cancer immunotherapy. This paper outlines numerous immunoprevention strategies and how nanotechnology can be applied in immunoprevention. To comprehend the non-clinical and clinical evaluation of these cancer vaccines through clinical studies is essential for acceptance of the vaccines. MDPI 2022-10-16 /pmc/articles/PMC9610880/ /pubmed/36298592 http://dx.doi.org/10.3390/vaccines10101727 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Koyande, Navami Prabhakar Srivastava, Rupali Padmakumar, Ananya Rengan, Aravind Kumar Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
title | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
title_full | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
title_fullStr | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
title_full_unstemmed | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
title_short | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
title_sort | advances in nanotechnology for cancer immunoprevention and immunotherapy: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610880/ https://www.ncbi.nlm.nih.gov/pubmed/36298592 http://dx.doi.org/10.3390/vaccines10101727 |
work_keys_str_mv | AT koyandenavamiprabhakar advancesinnanotechnologyforcancerimmunopreventionandimmunotherapyareview AT srivastavarupali advancesinnanotechnologyforcancerimmunopreventionandimmunotherapyareview AT padmakumarananya advancesinnanotechnologyforcancerimmunopreventionandimmunotherapyareview AT renganaravindkumar advancesinnanotechnologyforcancerimmunopreventionandimmunotherapyareview |